Chemotactic factors stimulate CD18-dependent canine neutrophil adherence and motility on lung fibroblasts.
The mechanisms by which neutrophils migrate through the alveolar interstitium during acute lung inflammation are unknown. We wished to determine whether platelet-activating factor (PAF) and IL-8, two important mediators in neutrophil transendothelial migration, stimulated neutrophil adherence and motility on lung fibroblasts. Canine fibroblasts grown from lung explants were characterized by light and electron microscopy, and flow cytometry. Unstimulated neutrophils adhered poorly (less than 2%) to cultured fibroblasts. However, neutrophils stimulated with PAF (20-200 nM) showed a dose-dependent increase in adherence that was largely (70%) mediated by the beta 2 (CD11/CD18) integrins; adherence was less dependent (50%) on fibroblast intercellular adhesion molecule-1. Conversely, neutrophils stimulated with canine rIL-8 did not increase their adherence to fibroblasts. PAF-stimulated neutrophils were nonmotile on the surface of the fibroblast, but subsequent addition of rIL-8 (10(-8) M) induced motility that was entirely CD1 8 dependent. Fibroblasts stimulated with human rTNF-alpha or Escherichia coli endotoxin (LPS) were a significant source of IL-8 mRNA. In response to rTNF-alpha (50 U/ml), IL-8 mRNA was detected at 2 h by northern blot analysis; it peaked at 6 h and returned to baseline by 24 h. Fibroblasts stimulated with rTNF-alpha secreted IL-8 protein into the culture medium; secreted IL-8 was chemotactic for neutrophils. These data suggest that fibroblasts can function not only as an adhesive substrate, but also as a source of stimulation for neutrophil migration through the inflamed alveolar interstitium.
Burns
A R
AR
Speros P. Martel Laboratory, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Simon
S I
SI
Kukielka
G L
GL
Rowen
J L
JL
Lu
H
H
Mendoza
L H
LH
Brown
E S
ES
Entman
M L
ML
Smith
C W
CW
D000818:Animals; D018821:CD18 Antigens / Q000187:drug effects* / Q000502:physiology*; D002448:Cell Adhesion / Q000187:drug effects / Q000276:immunology; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology*; D002478:Cells, Cultured; D002630:Chemotactic Factors / Q000494:pharmacology*; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D004285:Dogs; D005260:Female; D005347:Fibroblasts / Q000276:immunology* / Q000378:metabolism / Q000648:ultrastructure; D016209:Interleukin-8 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology; D008168:Lung / Q000276:immunology* / Q000648:ultrastructure; D008297:Male; D009504:Neutrophils / Q000276:immunology* / Q000648:ultrastructure; D010972:Platelet Activating Factor / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D011994:Recombinant Proteins / Q000494:pharmacology
D018821:CD18 Antigens; D002630:Chemotactic Factors; D016209:Interleukin-8; D010972:Platelet Activating Factor; D012333:RNA, Messenger; D011994:Recombinant Proteins